RELMADA THERAPEUTICS INC
RLMD · NASDAQ
更新於 2026-10-15 06:44:56
- 今日最高
- $3.37
- 今日最低
- $3.19
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $3.31
- 昨天收盤價
- $3.24
- 成交量
- 1.35M
- 市值
- $345.61M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.96
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Pharmaceuticals
- 子行業
- BIOTECHNOLOGY
- 總部
- 2222 PONCE DE LEON BLVD., CORAL GABLES, FL, UNITED STATES, 33134
- 國家
- US
- 上市日期
- 2014-03-03
- 財年截止
- December
- 流通股數
- 104.89M
- CIK
- 0001553643
- 官方網址
- www.relmada.com
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to treat central nervous system (CNS) diseases and other disorders in the United States. The company is headquartered in New York, New York.
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
營業支出
2026-06-30
$15.01M
2026-03-31
$19.46M
2025-12-31
$20.33M
2025-09-30
$10.32M
淨利潤
2026-06-30
-$12.91M
2026-03-31
-$19.05M
2025-12-31
-$19.86M
2025-09-30
-$10.09M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.11
2026-03-31
$-0.22
2025-12-31
$-0.29
2025-09-30
$-0.30
息稅折舊攤銷前利潤
2026-06-30
-$12.91M
2026-03-31
-$19.05M
2025-12-31
-$19.86M
2025-09-30
-$10.09M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $0 | $0 | $0 | $0 |
| 營業支出 | $15.01M | $19.46M | $20.33M | $10.32M |
| 淨利潤 | -$12.91M | -$19.05M | -$19.86M | -$10.09M |
| 淨利潤率 | -- | -- | -- | -- |
| 每股收益 | $-0.11 | $-0.22 | $-0.29 | $-0.30 |
| 息稅折舊攤銷前利潤 | -$12.91M | -$19.05M | -$19.86M | -$10.09M |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。